title: Infliximab is the drug we have been waiting for in Crohn's disease.
authors.affiliation: Department of Medicine, University Hospital Gasthuisberg, Leuven, Belgium.
authors.forename: P
authors.initials: P
authors.lastname: Rutgeerts
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D001323:Autoantibodies; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D004334:Drug Administration Schedule; D005765:Gastrointestinal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D011379:Prognosis
chemical_list: D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D005765:Gastrointestinal Agents; D000069285:Infliximab